rs4900

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_002067.5(GNA11):​c.771C>T​(p.Thr257Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.457 in 1,612,358 control chromosomes in the GnomAD database, including 172,418 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 12144 hom., cov: 32)
Exomes 𝑓: 0.47 ( 160274 hom. )

Consequence

GNA11
NM_002067.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.579

Publications

33 publications found
Variant links:
Genes affected
GNA11 (HGNC:4379): (G protein subunit alpha 11) The protein encoded by this gene belongs to the family of guanine nucleotide-binding proteins (G proteins), which function as modulators or transducers in various transmembrane signaling systems. G proteins are composed of 3 units: alpha, beta and gamma. This gene encodes one of the alpha subunits (subunit alpha-11). Mutations in this gene have been associated with hypocalciuric hypercalcemia type II (HHC2) and hypocalcemia dominant 2 (HYPOC2). Patients with HHC2 and HYPOC2 exhibit decreased or increased sensitivity, respectively, to changes in extracellular calcium concentrations. [provided by RefSeq, Dec 2013]
GNA11 Gene-Disease associations (from GenCC):
  • autosomal dominant hypocalcemia 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • congenital hemangioma
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • familial hypocalciuric hypercalcemia 2
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet
  • autosomal dominant hypocalcemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 19-3119241-C-T is Benign according to our data. Variant chr19-3119241-C-T is described in ClinVar as [Benign]. Clinvar id is 258548.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.579 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.473 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNA11NM_002067.5 linkc.771C>T p.Thr257Thr synonymous_variant Exon 6 of 7 ENST00000078429.9 NP_002058.2 P29992

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNA11ENST00000078429.9 linkc.771C>T p.Thr257Thr synonymous_variant Exon 6 of 7 1 NM_002067.5 ENSP00000078429.3 P29992

Frequencies

GnomAD3 genomes
AF:
0.384
AC:
58250
AN:
151846
Hom.:
12137
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.215
Gnomad AMI
AF:
0.281
Gnomad AMR
AF:
0.410
Gnomad ASJ
AF:
0.413
Gnomad EAS
AF:
0.410
Gnomad SAS
AF:
0.422
Gnomad FIN
AF:
0.368
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.477
Gnomad OTH
AF:
0.395
GnomAD2 exomes
AF:
0.427
AC:
107299
AN:
251156
AF XY:
0.431
show subpopulations
Gnomad AFR exome
AF:
0.210
Gnomad AMR exome
AF:
0.422
Gnomad ASJ exome
AF:
0.402
Gnomad EAS exome
AF:
0.407
Gnomad FIN exome
AF:
0.375
Gnomad NFE exome
AF:
0.476
Gnomad OTH exome
AF:
0.436
GnomAD4 exome
AF:
0.465
AC:
679315
AN:
1460394
Hom.:
160274
Cov.:
42
AF XY:
0.465
AC XY:
337506
AN XY:
726498
show subpopulations
African (AFR)
AF:
0.209
AC:
7001
AN:
33440
American (AMR)
AF:
0.417
AC:
18650
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.407
AC:
10628
AN:
26130
East Asian (EAS)
AF:
0.438
AC:
17368
AN:
39690
South Asian (SAS)
AF:
0.422
AC:
36249
AN:
85938
European-Finnish (FIN)
AF:
0.376
AC:
20037
AN:
53286
Middle Eastern (MID)
AF:
0.436
AC:
2515
AN:
5768
European-Non Finnish (NFE)
AF:
0.486
AC:
539657
AN:
1111100
Other (OTH)
AF:
0.451
AC:
27210
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
18153
36305
54458
72610
90763
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15776
31552
47328
63104
78880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.384
AC:
58289
AN:
151964
Hom.:
12144
Cov.:
32
AF XY:
0.379
AC XY:
28141
AN XY:
74266
show subpopulations
African (AFR)
AF:
0.216
AC:
8944
AN:
41484
American (AMR)
AF:
0.410
AC:
6255
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.413
AC:
1433
AN:
3470
East Asian (EAS)
AF:
0.411
AC:
2118
AN:
5158
South Asian (SAS)
AF:
0.421
AC:
2011
AN:
4772
European-Finnish (FIN)
AF:
0.368
AC:
3894
AN:
10582
Middle Eastern (MID)
AF:
0.432
AC:
127
AN:
294
European-Non Finnish (NFE)
AF:
0.477
AC:
32414
AN:
67914
Other (OTH)
AF:
0.397
AC:
837
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1752
3504
5257
7009
8761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.429
Hom.:
8134
Bravo
AF:
0.378
Asia WGS
AF:
0.410
AC:
1426
AN:
3478
EpiCase
AF:
0.472
EpiControl
AF:
0.472

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Thr257Thr in exon 6 of GNA11: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 46.79% (31211/66704) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac. broadinstitute.org; dbSNP rs4900). -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
13
DANN
Benign
0.68
PhyloP100
0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4900; hg19: chr19-3119239; COSMIC: COSV50020241; COSMIC: COSV50020241; API